# Douglas I. Lin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/douglas-i-lin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,196 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 36 |
| i10-index | 73 |
| Last Known Institution | Boston Foundation |
| OpenAlex ID | https://openalex.org/A5053703940 |
| ORCID iD | 0000-0003-0105-9760 |
| Works | 248 |

## Researcher papers

- [High grade serous ovarian carcinomas originate in the fallopian tube](https://scholariq.org/papers/high-grade-serous-ovarian-carcinomas-originate-in-the-fallopian-tube/)
- [p63 Is a Prostate Basal Cell Marker and Is Required for Prostate Development](https://scholariq.org/papers/p63-is-a-prostate-basal-cell-marker-and-is-required-for-prostate-development/)
- [Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex](https://scholariq.org/papers/phosphorylation-dependent-ubiquitination-of-cyclin-d1-by-the-scffbx4-b/)
- [Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)](https://scholariq.org/papers/molecular-and-clinical-determinants-of-response-and-resistance-to-rucaparib-for/)
- [Mutations in Fbx4 Inhibit Dimerization of the SCFFbx4 Ligase and Contribute to Cyclin D1 Overexpression in Human Cancer](https://scholariq.org/papers/mutations-in-fbx4-inhibit-dimerization-of-the-scffbx4-ligase-and-contribute-to/)
- [Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation](https://scholariq.org/papers/integrative-analysis-of-a-large-real-world-cohort-of-small-cell-lung-cancer-2/)
- [Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication](https://scholariq.org/papers/nuclear-accumulation-of-cyclin-d1-during-s-phase-inhibits-cul4-dependent-cdt1/)
- [Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling](https://scholariq.org/papers/characterization-of-clinical-cases-of-advanced-papillary-renal-cell-carcinoma/)
- [Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling](https://scholariq.org/papers/characterization-of-clinical-cases-of-collecting-duct-carcinoma-of-the-kidney/)
- [A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases](https://scholariq.org/papers/a-pan-cancer-analysis-of-pd-l1-immunohistochemistry-and-gene-amplification-tumor/)
- [Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histological transformation](https://scholariq.org/papers/integrative-analysis-of-a-large-real-world-cohort-of-small-cell-lung-cancer/)
- [Abstract 931: Comprehensive analysis of 3,600 small cell lung cancer cases reveals rare genetic subtypes and multiple mechanisms of histological transformation](https://scholariq.org/papers/abstract-931-comprehensive-analysis-of-3-600-small-cell-lung-cancer-cases/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Researcher university

- [Boston Foundation](https://scholariq.org/institutions/boston-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
